Findings in a nutshell:
610% increased risk of myocarditis following mRNA platform injection.
378% increased risk of acute disseminated encephalomyelitis (ADEM) following mRNA injection.
323% increased risk of cerebral venous sinus thrombosis (CVST) following viral-vector injection.
249% increased risk of Guillain-Barré syndrome (GBS) following viral-vecto…


